Application 083900
- Type
- ANDA
- Sponsor
- SMITH KLINE & FRENCH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BENZEDRINE | AMPHETAMINE SULFATE | Tablet; Oral | 5MG | No | No |
| 002 | BENZEDRINE | AMPHETAMINE SULFATE | Tablet; Oral | 10MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amphetamine Sulfate | AMPHETAMINE SULFATE | SpecGx LLC | 00242264-40d8-4267-a91a-727a1f088616 | 2023-05-24 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.